PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series

BACKGROUND: Gallbladder cancer (GBC) is a fatal cancer, and the efficacy of the current standard second-line chemotherapy for GBC is limited. Novel therapies need to be explored. This retrospective analysis was aimed to investigate the outcomes of patients treated at West China Hospital with PD-1 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Sirui, Yu, Jing, Huang, Qiyue, Zhou, Nan, Gou, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709255/
https://www.ncbi.nlm.nih.gov/pubmed/36465365
http://dx.doi.org/10.3389/fonc.2022.1006075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709255/
https://www.ncbi.nlm.nih.gov/pubmed/36465365
http://dx.doi.org/10.3389/fonc.2022.1006075

Ejemplares similares